Biochemistry Terms Starting With U
Biochemistry Glossary: U
Ubiquinone
/yoo-BIK-wih-nohn/ · Latin 'ubique' (everywhere) + 'quinone' (chemical compound with two carbonyl groups)
Ubiquinone is a lipid-soluble electron carrier embedded in the mitochondrial inner membrane that shuttles electrons between Complex I or Complex II and Complex III during oxidative phosphorylation.
Ubiquinone accepts two electrons and two protons to become ubiquinol, then diffuses laterally through the lipid bilayer to deliver those electrons to the cytochrome bc1 complex. Humans synthesize ubiquinone-10, which carries 10 isoprenoid units in its hydrophobic tail, while Escherichia coli produces ubiquinone-8 with only 8 units; the tail length determines how deeply the molecule embeds in the membrane. During the Q cycle at Complex III, ubiquinone undergoes sequential one-electron reductions through a semiquinone radical intermediate, a mechanism that couples electron transfer to the pumping of four protons per pair of electrons across the inner membrane.
This proton pumping contributes directly to the electrochemical gradient that ATP synthase uses to phosphorylate ADP.
Coenzyme Q10 supplements are widely sold for cardiovascular support, yet a 2022 meta-analysis of randomized controlled trials found no significant reduction in all-cause mortality among patients with heart failure who took supplemental ubiquinone-10, despite measurable increases in plasma ubiquinone levels.
Mitochondria Functions →Ubiquinone only shuttles electrons between protein complexes in the electron transport chain. When reduced to ubiquinol, it carries both electrons and protons across the membrane, directly contributing to the proton gradient that drives ATP synthesis rather than merely relaying electrons.
The nematode Caenorhabditis elegans requires ubiquinone-9 for cellular respiration, and worms carrying loss-of-function mutations in the clk-1 gene, which encodes a ubiquinone biosynthesis enzyme, show a 50% extension of lifespan alongside severely reduced mitochondrial electron transport activity.
UDP-Glucose
/ YOO-dee-PEE GLOO-kohs / · English abbreviation: UDP from uridine diphosphate; glucose from Greek gleukos meaning sweet wine
UDP-Glucose is an activated sugar nucleotide in which glucose is covalently linked to uridine diphosphate, making it a high-energy glucose donor for biosynthetic reactions including glycogen synthesis and glycoprotein formation.
Glycogen synthase in mammalian liver cells transfers glucose from UDP-glucose to the non-reducing end of a growing glycogen chain at roughly 10 glucose residues per second, with the energy released by breaking the glucose-UDP bond driving an otherwise thermodynamically unfavorable condensation. Formation of UDP-glucose from glucose-1-phosphate and UTP, catalyzed by UDP-glucose pyrophosphorylase, releases inorganic pyrophosphate; subsequent hydrolysis of that pyrophosphate by pyrophosphatase pulls the reaction to completion. In Escherichia coli, UDP-glucose also donates glucose units to lipopolysaccharide precursors in the outer membrane, linking central carbon metabolism to cell-surface assembly.
The free energy of hydrolysis of the glucose-UDP bond is approximately 7.3 kcal/mol, comparable to that of ATP hydrolysis.
Cellulose synthase complexes in plant cell walls use UDP-glucose to spin out cellulose microfibrils at rates of roughly 300 glucose residues per minute per complex; globally, plants produce an estimated 180 billion metric tons of cellulose annually, making UDP-glucose the precursor to the most abundant organic polymer on Earth.
Building Blocks of Carbohydrates →Glycogen synthase can add free glucose directly to a glycogen chain. Glucose must first be activated to UDP-glucose before glycogen synthase can incorporate it, because the enzyme has no mechanism to catalyze condensation using unactivated glucose.
During recovery from intense exercise, human skeletal muscle cells convert glucose-1-phosphate to UDP-glucose via UDP-glucose pyrophosphorylase, then glycogen synthase incorporates each activated glucose into glycogen stores at a rate that can restore muscle glycogen from near-depletion to normal within 24 hours when carbohydrate intake is adequate.
Uncompetitive Inhibition
/ un-kom-PET-i-tiv in-hi-BI-shun / · Latin 'un-' (not) + 'competere' (to strive together) + 'inhibere' (to hold back)
Uncompetitive inhibition is a type of enzyme inhibition in which the inhibitor binds exclusively to the enzyme-substrate complex rather than to the free enzyme, reducing both the maximum reaction velocity and the apparent Michaelis constant by the same factor.
Because both Vmax and Km decrease proportionally, the ratio Km/Vmax remains constant, producing parallel lines on a Lineweaver-Burk double-reciprocal plot, a diagnostic signature that distinguishes uncompetitive inhibition from competitive and mixed inhibition. Lithium ions inhibit inositol monophosphatase in human neurons through an uncompetitive mechanism, binding only after inositol monophosphate occupies the active site; this selectivity for the enzyme-substrate complex is thought to underlie part of lithium’s therapeutic effect in bipolar disorder. Unlike competitive inhibitors, uncompetitive inhibitors grow more potent as substrate concentration rises, because higher substrate levels generate more enzyme-substrate complex for the inhibitor to bind.
This counterintuitive property makes uncompetitive inhibitors particularly effective in metabolic pathways that operate near substrate saturation.
BIRT 377, an experimental inhibitor of the immune-cell integrin LFA-1, displays uncompetitive kinetics with respect to its ligand ICAM-1, demonstrating that uncompetitive inhibition occurs in receptor-ligand systems outside classical enzyme catalysis and has been explored as a strategy for anti-inflammatory drug design.
Uncompetitive inhibitors compete with the substrate for the active site. Uncompetitive inhibitors cannot bind the free enzyme at all; they attach to a distinct site on the enzyme-substrate complex only after the substrate is already bound.
Phosphoenolpyruvate binds an uncompetitive inhibitor of hexokinase in Saccharomyces cerevisiae by binding only to the hexokinase-glucose complex, reducing glycolytic flux when downstream intermediates accumulate; at glucose concentrations above 5 mM, inhibition by phosphoenolpyruvate increases measurably because more enzyme-substrate complex is available for inhibitor binding.
Uncoupling Protein
/ un-KUP-ling PRO-teen / · English 'uncoupling' (separating linked processes) + Latin 'proteinus' (primary, of first importance)
Uncoupling protein is a mitochondrial inner membrane protein that transports protons from the intermembrane space into the matrix, dissipating the electrochemical gradient and releasing energy as heat rather than driving ATP synthesis.
UCP1, expressed in brown adipose tissue, generates non-shivering thermogenesis in newborn humans and hibernating mammals by short-circuiting the proton gradient that ATP synthase would otherwise use. At full activation, UCP1 can increase the heat output of brown adipose tissue up to 300-fold above basal levels, a capacity that keeps newborns warm before their shivering reflex matures. Four additional isoforms, UCP2 through UCP5, appear in tissues ranging from skeletal muscle to brain, though their physiological roles remain more debated than that of UCP1.
Long-chain fatty acids and purine nucleotides regulate UCP1 activity reciprocally: free fatty acids activate the protein, while GDP and ATP inhibit it, linking thermogenic output to the cell’s energy status.
Naked mole rats (Heterocephalus glaber) show unusually low UCP1 expression compared to other rodents of similar size, which may contribute to their near-poikilothermic physiology; these animals maintain body temperatures within about 2°C of their tunnel environment rather than defending a fixed set point.
Uncoupling proteins waste energy by reducing ATP production. Proton leak through uncoupling proteins converts the mitochondrial gradient into heat, which warm-blooded animals use to maintain core body temperature, regulate metabolic rate, and protect tissues from oxidative damage caused by excess electron transport activity.
Newborn humans express high concentrations of UCP1 in interscapular brown adipose tissue, a deposit that can account for up to 5% of body weight at birth and generates enough heat to raise core temperature by several degrees Celsius within minutes of cold exposure.
Unsaturated Fatty Acid
/ un-SAT-ur-ay-ted FAT-ee AS-id / · Latin 'un-' (not) + 'saturare' (to fill) + 'acere' (to be sour)
Unsaturated fatty acid is a fatty acid whose hydrocarbon chain contains one or more carbon-carbon double bonds, each of which introduces a rigid bend that prevents close molecular packing.
Each double bond removes two hydrogen atoms from the carbon chain relative to the fully saturated form and introduces a roughly 30-degree kink when the bond is in the cis configuration. These kinks disrupt van der Waals interactions between neighboring chains, lowering the melting point and keeping membrane lipids fluid at physiological temperatures. Atlantic salmon (Salmo salar) accumulates high concentrations of docosahexaenoic acid, a 22-carbon omega-3 fatty acid with 6 double bonds, in its flesh; this fatty acid keeps neuronal and retinal membranes fluid in cold water where a saturated equivalent would solidify.
Cells in the mammalian brain incorporate docosahexaenoic acid into phospholipids at concentrations exceeding 15% of total fatty acids, reflecting the membrane fluidity demands of rapid synaptic signaling.
Trans unsaturated fatty acids, produced industrially by partial hydrogenation of vegetable oils, raise LDL cholesterol and lower HDL cholesterol more severely than saturated fats do; the U.S. Food and Drug Administration banned partially hydrogenated oils from the food supply in 2018 after decades of epidemiological evidence linked trans fat consumption to increased cardiovascular disease risk.
Building Blocks of Lipids →All unsaturated fats are equally beneficial to health. The geometry of the double bond determines biological effect: cis unsaturated fatty acids lower LDL cholesterol and support membrane function, while trans unsaturated fatty acids raise cardiovascular disease risk and are now banned from most commercial food products.
Avocado (Persea americana) flesh derives roughly 71% of its fatty acid content from oleic acid, an 18-carbon monounsaturated fatty acid with a single cis double bond at the ninth carbon, which keeps the fruit's lipid droplets liquid at room temperature and contributes to its characteristic creamy texture.
Urea Cycle
/ yoo-REE-uh SY-kul / · From Greek ouron (urine) + Latin cyclus (circle), named for the circular metabolic pathway that produces urea
Urea Cycle is a metabolic pathway in the liver that converts toxic ammonia into urea for excretion in urine.
Humans process approximately 20 grams of nitrogen daily through this pathway, primarily from dietary protein breakdown. Five enzymatic steps carry out the conversion, beginning with carbamoyl phosphate formation in the mitochondrial matrix and ending with arginine cleavage in the cytoplasm, so the cycle spans two cellular compartments. Ureotelic organisms, including mammals and adult amphibians, rely on this route to safely eliminate nitrogenous waste, whereas aquatic animals such as goldfish (Carassius auratus) excrete ammonia directly into surrounding water.
Each full turn of the cycle consumes four ATP equivalents, making nitrogen disposal a metabolically costly process.
The urea cycle was the first metabolic cycle to be discovered, identified by Hans Krebs and Kurt Henseleit in 1932, five years before Krebs described the citric acid cycle.
History of Biochemistry →The urea cycle takes place entirely in the liver. The pathway is split between the mitochondrial matrix and the cytoplasm, with carbamoyl phosphate synthetase I operating in the mitochondria and argininosuccinate synthetase working in the cytoplasm.
Branches of Biochemistry →The ornate horned frog (Ceratophrys ornata) shifts from ammonia excretion to urea production during metamorphosis as it transitions from an aquatic tadpole to a terrestrial adult, with urea synthesis rising more than tenfold over the course of the transformation.
Uric Acid
/YUR-ik AS-id/ · Latin urina (urine) + acidus (sour)
Uric Acid is a nitrogenous waste product formed from the breakdown of purines that birds and reptiles excrete as a semi-solid paste and that humans excrete primarily through urine.
Birds and reptiles convert approximately 80 to 90 percent of their nitrogenous waste into uric acid rather than urea, conserving water during excretion. Humans normally maintain blood uric acid levels between 3.5 and 7.2 milligrams per deciliter, with the enzyme xanthine oxidase converting xanthine to uric acid in the final step of purine degradation. When uric acid exceeds this range, crystals of monosodium urate deposit in joints, causing the inflammatory condition known as gout.
Dalmatian dogs excrete roughly ten times more uric acid than other breeds due to a genetic mutation affecting urate transport in kidney tubule cells.
Hummingbirds produce uric acid crystals that make up about 60 percent of their total waste mass, which they excrete as white droppings during flight without needing to stop.
Uric acid is nothing more than a metabolic waste product the body must eliminate. Uric acid circulates in blood as a potent antioxidant, and some researchers propose that its rise in primate evolution contributed to the relatively long lifespan of humans compared with other mammals.
The Gila monster (Heloderma suspectum) stores uric acid in specialized bladder tissues during dry seasons, reabsorbing water while retaining crystalline waste until rainfall arrives.